Sekisui Chemical to Buy American Diagnostica Inc. to Enter the U.S. Diagnostic Drug Market

March 18, 2009 |

1 min read

NEW YORK, March 17 - Sekisui Chemical Co Ltd intends to acquire American Diagnostica Inc to enter the U.S. diagnostic drug market, the financial daily Nikkei said in its Wednesday edition.

Mergers & acquisitions

MORE ON THIS TOPIC

China High Resolution Innovation Concept

Insights

Uptick in Dealmaking, Chinese Partnerships Drive Biotech’s Comeback

December 17, 2025

·

3 min read

·

Jennifer Smith-Parker

Pictured: Blue Sanofi sign on building in Germany at night

Alzheimer’s disease

Sanofi’s Neuro Push Arrives in Seoul With $1B+ Alzheimer’s Play

December 16, 2025

·

1 min read

·

Tristan Manalac

Illustration of businessman running back around

Autoimmune disease

Sanofi Taps Dren Again in up to $1.7B Autoimmune Partnership

December 15, 2025

·

1 min read

·

Annalee Armstrong

Rheumatoid arthritis (RA) commonly causes inflammation in the hands, leading to pain, swelling, and stiffness in the joints, particularly the small joints of the fingers and wrists. This inflammation results from the immune system attacking the body's own joint tissues, causing the synovium (lining of the joint) to become inflamed and release chemicals that damage nearby tissues.

Mergers & acquisitions

Sobi Makes $1.5B Gout Play With Arthrosi Acquisition

December 15, 2025

·

2 min read

·

Tristan Manalac